SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Sai Parenterals Ltd

BSE: 544742 NSE: SAIPARENT ISIN: INE0H9F01037
  |   Sector:  Healthcare   |   Industry:  Pharmaceuticals & Drugs

Snapshot

Q.1 Which industry/sub-sector does Sai Parenterals Ltd belong to?
Sai Parenterals Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.
Q.2 Is Sai Parenterals Ltd a good quality company?
Sai Parenterals Ltd is a weak quality company, based on a inconsistent 10 year financial track record.
Q.3 Is Sai Parenterals Ltd undervalued or overvalued?
Sai Parenterals Ltd appears Overvalued, as its key valuation ratios are above with their past averages.
Q.4 Is Sai Parenterals Ltd a good buy now?
Sai Parenterals Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Sai Parenterals Ltd?
Sai Parenterals Ltd revenue growth is % for FY- , which is in line with its 5 year CAGR of 0% , indicating stable growth.
Q.2 Gross Profit margin of Sai Parenterals Ltd?
Sai Parenterals Ltd Gross profit margin which is the profit after deduction of direct costs, is 13.5% for FY-2023 , which is in line with its 5 year median of 13.5% , indicating stable margins.
Q.3 Operating Profit Margin of Sai Parenterals Ltd?
Sai Parenterals Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 20.28% for FY-2023 , which is in line with its 5 year median of 20.28% indicating stable margins.
Q.4 Net Profit Margin of Sai Parenterals Ltd?
Sai Parenterals Ltd Net Profit Margin is 4.74% for FY-2023 , is in line with with its 5 year median of 4.74%, indicating stable margins.
Current Level Historic Median
Gross Profit Margin 13.5 13.5
Operating Profit Margin 20.28 20.28
Net Profit Margin 4.74 4.74
Q.5 Return on Asset of Sai Parenterals Ltd?
Sai Parenterals Ltd Return on Asset is 3.42%, which is in line with its 5 year historical median of 3.42%, indicating stable asset utilization efficiency.
Q.6 Return on Equity (ROE) of Sai Parenterals Ltd?
Sai Parenterals Ltd Return on equity is 14.56% for FY-2023 , which is in line with its historical median of 14.56%, indicating the business is making similar use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Sai Parenterals Ltd?
Sai Parenterals Ltd Return on capital employed is 12.97% for FY-2023 , which is below its estimated weighted average cost of capital(WACC) 14%, indicating value preservation.
Q.8 Cash conversion cycle of Sai Parenterals Ltd?
Sai Parenterals Ltd Cash conversion cycle is 0 days, in line with its historical median of 0 days, indicating stable working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.72 0.72
ROE 14.56 14.56
ROCE 12.97 12.97
Cash Conversion Cycle - -
Q.9 Debt to Equity ratio of Sai Parenterals Ltd?
Sai Parenterals Ltd Debt-to-Equity ratio is 2.18 , which is above with the industry average of 0.15 , indicating higher debt levels in the industry.
Q.10 Debt to cash flow from operations of Sai Parenterals Ltd?
Sai Parenterals Ltd Debt to cash flow from operations is -3.29 , which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Sai Parenterals Ltd?
Promoters hold 51.16% of the Sai Parenterals Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Sai Parenterals Ltd vs industry peers?
Sai Parenterals Ltd revenue CAGR is 0.00% , compared to the industry median CAGR of 5.54% , indicating slower growth and losing its market share.
Profit Metrics
Current Level Industry Median
Revenue 96.8 137.1
Gross Profit 13.1 15.1
Operating Profit 19 16
Net Profit 5 5.6
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.72 0.8
ROE 14.56 8.91
ROCE 12.97 11.59
Cash Conversion Cycle (days) - 76

Valuation & price assessment

Q.1 Stock return of Sai Parenterals Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price - - - -
Q.3 Valuation ratios of Sai Parenterals Ltd vs historical?
The current P/E is higher that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 452.88 0.00 40.28
Price to Book - 0.00 2.77
Price to Sales 21.45 0.00 2.65
EV to EBITDA 114.16 0.00 15.67

Check more companies

1. Ajanta Pharma
2. JB Chem & Pharma
3. Emcure Pharma
4. Gland Pharma
5. Wockhardt
6. Pfizer
7. Astrazeneca Pharma I
8. Sai Life Sciences
9. Natco Pharma
10. Eris Lifesciences
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×